Lifeline Biotechnologies Inc (LLBO)

[voo]

Patents exercised and Asia deal LLBO -Cyrcadia US - Cyrcadia Asia

Q2 states that 12,67 M shares is 47% of all OS Cyrcadia which means OS Cyrcadia at that time was little less than 27M

A bit later the Asia deal means
* 250M a year for four years to CI
* 330K (that just was paid by CI to LLBO) by issuing new shares
* 500K because of issuing new shares
* In 2018 another 500K because of issuing new shares
* Product development upgrading by CA worth 2.9M (that means CI doesn't need to invest further)
* 2,5% equity interest in CA
* License CI for its own market

So this proves the Asia deal was highly needed to keep this thing rolling!

Also means CI issued 6M:
4.67M to LLBO
0.33M to shareholders of CA @ $1 a share
0.5M to shareholders of CA @ $1 a share
Another 0.5M to shareholders of CA @ $1 a share in 2018

That means LLBO has then 12,67 of 28M= 45% of CI
Thus 1,125% of CA